TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

MEDI-PHYSICS

CardiovascularOncology
Specialty

MEDI-PHYSICS is a specialty pharmaceutical company focused on Cardiovascular, Oncology.

1996
Since
2
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 86%
1 drugs
Oncology 14%
0 drugs Phase 1: 1

Pipeline Strength Pro

Loading...